These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24047697)

  • 21. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG island shore methylation regulates caveolin-1 expression in breast cancer.
    Rao X; Evans J; Chae H; Pilrose J; Kim S; Yan P; Huang RL; Lai HC; Lin H; Liu Y; Miller D; Rhee JK; Huang YW; Gu F; Gray JW; Huang TM; Nephew KP
    Oncogene; 2013 Sep; 32(38):4519-28. PubMed ID: 23128390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
    Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
    Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
    Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
    Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas.
    Bates GJ; Fox SB; Han C; Launchbury R; Leek RD; Harris AL; Banham AH
    Breast Cancer Res Treat; 2008 Oct; 111(3):453-9. PubMed ID: 18026833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel roles for ERK5 and cofilin as critical mediators linking ERα-driven transcription, actin reorganization, and invasiveness in breast cancer.
    Madak-Erdogan Z; Ventrella R; Petry L; Katzenellenbogen BS
    Mol Cancer Res; 2014 May; 12(5):714-27. PubMed ID: 24505128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.
    Kim K; Madak-Erdogan Z; Ventrella R; Katzenellenbogen BS
    Horm Cancer; 2013 Apr; 4(2):78-91. PubMed ID: 23250869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FoxO3a Inhibits Tamoxifen-Resistant Breast Cancer Progression by Inducing Integrin α5 Expression.
    Ricci E; Fava M; Rizza P; Pellegrino M; Bonofiglio D; Casaburi I; Lanzino M; Giordano C; Bruno R; Sirianni R; Barone I; Sisci D; Morelli C
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foxo3a expression is a prognostic marker in breast cancer.
    Jiang Y; Zou L; Lu WQ; Zhang Y; Shen AG
    PLoS One; 2013; 8(8):e70746. PubMed ID: 23967095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells.
    Gunnarsdóttir FB; Hagerling C; Bergenfelz C; Mehmeti M; Källberg E; Allaoui R; Mohlin S; Påhlman S; Larsson C; Jirström K; Bexell D; Leandersson K
    Exp Cell Res; 2020 May; 390(1):111932. PubMed ID: 32145253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
    Karmakar S; Jin Y; Nagaich AK
    J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z; Reierstad S; Huang CC; Bulun SE
    Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
    Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
    Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
    Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms.
    Platet N; Cunat S; Chalbos D; Rochefort H; Garcia M
    Mol Endocrinol; 2000 Jul; 14(7):999-1009. PubMed ID: 10894150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells.
    Moy I; Todorović V; Dubash AD; Coon JS; Parker JB; Buranapramest M; Huang CC; Zhao H; Green KJ; Bulun SE
    Oncogene; 2015 Jan; 34(3):323-33. PubMed ID: 24413080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.
    Sanders DA; Ross-Innes CS; Beraldi D; Carroll JS; Balasubramanian S
    Genome Biol; 2013 Jan; 14(1):R6. PubMed ID: 23347430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells.
    John Mary DJS; Sikarwar G; Kumar A; Limaye AM
    Mol Cell Endocrinol; 2020 Mar; 504():110701. PubMed ID: 31926189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.